Kevin Patrick Danahy, Chief Commercial Officer at PULSE BIOSCIENCES, INC. (PLSE), sold 4,600 shares at $18.53 ($85K) on 2025-10-02, disclosed to the SEC on 2025-10-07.
Scheduled sale ($85k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PLSE | SELL | 2026-02-11 | $1.4M | — | Filing → |
| PLSE | SELL | 2025-09-22 | $747K | — | Filing → |
| PLSE | BUY | 2023-11-17 | $35K | — | Filing → |